Foreword by Ban Ki-moon
Prix Galien Pro Bono Humanitarian Award Winner: Philippe Douste-Blazy
Prix Galien Pro Bono Humanitarian Award Winner: William J. Clinton
Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel
Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine
Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria
Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives
Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
Linezolid, the first oxazolidinone antibacterial agent
The development of romiplostim for patients with immune thrombocytopenia
The discovery and development of rivaroxaban
A review of the history, properties, and use of the immunomodulatory compound lenalidomide
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine